Importer of Controlled Substances Application: Curium US LLC, 56051 [2023-17714]
Download as PDF
<![CDATA[
56051
ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 158 / Thursday, August 17, 2023 / Notices
(3) For the purpose of the
investigation so instituted, the following
are hereby named as parties upon which
this notice of investigation shall be
served:
(a) The complainant is:
Vicor Corporation, 25 Frontage Road,
Andover, MA 01810
(b) The respondents are the following
entities alleged to be in violation of
section 337, and are the parties upon
which the complaint is to be served:
Delta Electronics, Inc., 186, Ruey Kuang
Road, Neihu Dist., Taipei 114501,
Taiwan
Delta Electronics (Americas) Ltd., 46101
Fremont Blvd., Fremont, CA 94538
Delta Electronics (USA) Inc., 2925 E.
Plano Pkwy., Plano, TX 75074.
Cyntec Co., Ltd., 2 R&D 2nd Rd.,
Science-Based Industry Park, Hsinchu
30076, Taiwan
Quanta Computer Inc., No. 211, Wenhua
2nd Rd., Guishan Dist., Taoyuan City
333, Taiwan
Quanta Cloud Technology Inc., 1F, No.
211 Wenhua 2nd Rd., Guishan Dist.,
Taoyuan City 33377, Taiwan
Quanta Cloud Technology USA LLC,
1010 Rincon Circle, San Jose, CA
95131
Quanta Computer USA Inc., 45630
Northport Loop East, Fremont, CA
94538
Hon Hai Precision Industry Co. Ltd. (d/
b/a, Foxconn Technology Group), No.
2, Zihyou St., Tucheng Dist. New
Taipei City 236, Taiwan
Foxconn Industrial internet Co. Ltd., 2F
C1 Foxconn Technology Park, 2
Donghuan 2 Road Longhua,
Shenzhen, 518109 China
FII USA Inc. (a/k/a Foxconn Industrial,
Internet USA Inc.), 611 East
Wisconsin Ave., Milwaukee, WI
53202,
Ingrasys Technology Inc., 5F., No. 1188,
Nanqing Rd., Luzhu Dist., Taoyuan
City, Taiwan
Ingrasys Technology USA Inc., 2025
Gateway Place, Ste. 190, San Jose, CA
95110
(c) The Office of Unfair Import
Investigations, U.S. International Trade
Commission, 500 E Street SW, Suite
401, Washington, DC 20436; and
(4) For the investigation so instituted,
the Chief Administrative Law Judge,
U.S. International Trade Commission,
shall designate the presiding
Administrative Law Judge.
Responses to the complaint and the
notice of investigation must be
submitted by the named respondents in
accordance with section 210.13 of the
Commission’s Rules of Practice and
VerDate Sep<11>2014
21:36 Aug 16, 2023
Jkt 259001
Procedure, 19 CFR 210.13. Pursuant to
19 CFR 201.16(e) and 210.13(a), as
amended in 85 FR 15798 (March 19,
2020), such responses will be
considered by the Commission if
received not later than 20 days after the
date of service by the complainant of the
complaint and the notice of
investigation. Extensions of time for
submitting responses to the complaint
and the notice of investigation will not
be granted unless good cause therefor is
shown.
Failure of a respondent to file a timely
response to each allegation in the
complaint and in this notice may be
deemed to constitute a waiver of the
right to appear and contest the
allegations of the complaint and this
notice, and to authorize the
administrative law judge and the
Commission, without further notice to
the respondent, to find the facts to be as
alleged in the complaint and this notice
and to enter an initial determination
and a final determination containing
such findings, and may result in the
issuance of an exclusion order or a cease
and desist order or both directed against
the respondent.
By order of the Commission.
Issued: August 14, 2023.
Lisa Barton,
Secretary to the Commission.
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1234]
Importer of Controlled Substances
Application: Curium US LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Curium US LLC has applied
to be registered as an importer of basic
class(es) of controlled substance(s).
Refer to SUPPLEMENTARY INFORMATION
listed below for further drug
information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before September 18, 2023. Such
persons may also file a written request
for a hearing on the application on or
before September 18, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
PO 00000
Frm 00056
Fmt 4703
Sfmt 9990
In
accordance with 21 CFR 1301.34(a), this
is notice that on July 12, 2023, Curium
US LLC, 2703 Wagner Place, Maryland
Heights, Missouri 63043–3421, applied
to be registered as an importer of the
following basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
[FR Doc. 2023–17717 Filed 8–16–23; 8:45 am]
DATES:
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
Controlled substance
Drug
code
Schedule
Ecgonine .......................
9180
II
The company plans to import small
quantities of a derivative form of the
listed controlled substance to be used
for manufacturing purposes. No other
activities for these drug codes are
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023–17714 Filed 8–16–23; 8:45 am]
BILLING CODE P
E:\FR\FM\17AUN1.SGM
17AUN1
]]>Agencies
[Federal Register Volume 88, Number 158 (Thursday, August 17, 2023)]
[Notices]
[Page 56051]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-17714]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1234]
Importer of Controlled Substances Application: Curium US LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Curium US LLC has applied to be registered as an importer of
basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
September 18, 2023. Such persons may also file a written request for a
hearing on the application on or before September 18, 2023.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
requests for a hearing must be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on July 12, 2023, Curium US LLC, 2703 Wagner Place,
Maryland Heights, Missouri 63043-3421, applied to be registered as an
importer of the following basic class(es) of controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Ecgonine.......................................... 9180 II
------------------------------------------------------------------------
The company plans to import small quantities of a derivative form
of the listed controlled substance to be used for manufacturing
purposes. No other activities for these drug codes are authorized for
this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023-17714 Filed 8-16-23; 8:45 am]
BILLING CODE P
